Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are closely related viruses that differ mainly in where they prefer to live in the body, how they spread, and how often they cause repeat outbreaks. HSV-1 is far more common, infecting roughly 48% of Americans aged 14 to 49, while HSV-2 affects about 12%. Both cause lifelong infections, but the two types behave differently enough that knowing which one you have matters for understanding what to expect.
Where Each Type Prefers To Live
HSV-1 mostly causes infections in or around the mouth, the familiar cold sore. It spreads primarily through oral contact: kissing, sharing utensils, or skin-to-skin contact near the mouth. Most people pick it up during childhood or adolescence without even realizing it.
HSV-2 is almost exclusively a genital infection, transmitted through sexual contact with genital or anal skin, sores, or fluids. It rarely shows up on the face.
The important caveat: HSV-1 can also infect the genitals, typically through oral sex. This has become increasingly common. As fewer children acquire HSV-1 orally in childhood (likely due to improved hygiene), more teenagers and young adults encounter the virus for the first time during sexual activity, making genital HSV-1 a growing proportion of new genital herpes diagnoses.
How Prevalence Differs by Age
HSV-1 infection rates climb steadily with age. In the U.S., about 27% of 14- to 19-year-olds carry HSV-1, rising to 41% in people in their twenties, 54% in their thirties, and nearly 60% by their forties. HSV-2 follows the same upward pattern but at much lower numbers: under 1% in teenagers, about 8% in people in their twenties, 13% in their thirties, and 21% by their forties.
These numbers reflect a basic reality. HSV-1 spreads through everyday contact, so exposure accumulates over a lifetime. HSV-2 requires sexual transmission, so its prevalence rises more slowly and peaks lower.
Outbreak Frequency and Shedding
This is one of the biggest practical differences between the two types. Genital HSV-2 recurs far more often than genital HSV-1. If you have genital herpes caused by HSV-2, you can expect more frequent outbreaks, especially in the first year or two. Some people with frequent recurrences experience 10 or more episodes per year. Genital HSV-1, by contrast, tends to cause fewer repeat outbreaks, and the frequency drops quickly after the first year.
Viral shedding, when the virus is active on the skin without visible sores, follows a similar pattern. In the first year of genital HSV-1 infection, the virus sheds on about 12% of days. By 11 months that drops to 7%, and by two years it can fall to as low as 1.3% of days. HSV-2 sheds far more aggressively: about 34% of days in the first year, settling to around 17% of days even at the 10-year mark. This means HSV-2 carries a higher ongoing risk of unknowingly transmitting the virus to a partner, even between visible outbreaks.
Oral HSV-1 (cold sores) also recurs, though frequency varies widely from person to person. Some people get cold sores once a year or less; others deal with them several times a year, often triggered by stress, illness, or sun exposure.
Why HSV-2 Is Considered More Serious
From a public health standpoint, genital HSV-2 carries more weight. It accounts for roughly 90% of symptomatic genital herpes episodes and is substantially more likely to cause recurrent outbreaks. HSV-2 also increases the risk of acquiring HIV by two- to threefold, because the inflammation and tiny breaks in skin caused by herpes make it easier for HIV to enter the body.
That said, genital HSV-1 is not trivial. A first outbreak of genital HSV-1 can be just as painful as a first HSV-2 outbreak. The difference shows up over time: HSV-1 tends to quiet down faster, with fewer recurrences and less shedding as the years go on.
Testing and Diagnosis
If you have active sores, a swab test can identify whether HSV-1 or HSV-2 is responsible. This is the most reliable way to get a type-specific diagnosis.
Blood tests look for antibodies your immune system has built against each type, but they come with some important limitations. The accuracy depends heavily on which test your lab uses. Some widely used antibody tests for HSV-2 have a positive predictive value as low as 69%, meaning nearly one in three positive results could be a false positive, especially in populations where the infection is less common. Low-positive index values (scores just above the cutoff of 1.1) are particularly unreliable. One study found that over 60% of low-positive HSV-1 results and about 21% of low-positive HSV-2 results on a common automated test turned out to be false positives.
If you receive a positive blood test with a low index value, confirmatory testing with a more specific method is worth pursuing before drawing conclusions. Higher-specificity tests are available and perform much better, with specificity above 97% for HSV-2.
Treatment Works the Same for Both
Antiviral medications treat both HSV-1 and HSV-2 effectively. The same drugs are used regardless of type. You can take them during an outbreak to shorten healing time, or daily as suppressive therapy to reduce the frequency of recurrences and lower the chance of transmission to a partner.
Because genital HSV-2 recurs more often and sheds more persistently, daily suppressive therapy is more commonly recommended for people with HSV-2. People with genital HSV-1 are less likely to need daily medication after the first year, since outbreaks and shedding tend to taper off significantly on their own. For people with very frequent HSV-2 recurrences (10 or more episodes per year), higher doses of antiviral medication may be needed, as standard lower-dose regimens can be less effective in that group.
Can You Have Both Types?
Yes, though having one type offers partial protection against acquiring the other. If you already carry HSV-1 antibodies, you have some degree of immune defense against HSV-2, but it is not complete. Dual infection is possible and does occur. Blood testing can distinguish between the two, which is one reason type-specific testing matters when you want a full picture of your status.
What Actually Matters Day to Day
Knowing your type gives you a clearer sense of what to expect. Genital HSV-1 is likely to become a minor inconvenience over time, with infrequent outbreaks and declining shedding rates. Genital HSV-2 tends to be more persistent, with more outbreaks and higher ongoing transmission risk, but daily antiviral therapy significantly reduces both. Oral HSV-1 is extremely common and, for most people, causes occasional cold sores that are more of a nuisance than a health concern.
Both types are manageable, neither is curable, and the stigma surrounding herpes often outweighs the actual medical impact. The practical difference comes down to recurrence patterns and shedding rates, which influence decisions about treatment and conversations with partners.